Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/Core EBITDA

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 30.2832.74-0.120.23-0.23

What is the latest EV/Core EBITDA ratio of MANKIND PHARMA ?

The latest EV/Core EBITDA ratio of MANKIND PHARMA is 30.28 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202530.28
Mar202432.74
Mar2023-0.12
Mar20220.23
Mar2021-0.23

How is EV/Core EBITDA of MANKIND PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 30.28
-7.51
Mar2024 32.74
Positive
Mar2023 -0.12
Negative
Mar2022 0.23
Positive
Mar2021 -0.23 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/Core EBITDA ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,302.2 Cr 1.5% -3.5% -10.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,872.0 Cr 0.6% 3.6% -12.5% Stock Analytics
DIVIS LABORATORIES ₹175,706.0 Cr 1% 9.4% 8% Stock Analytics
CIPLA ₹127,449.0 Cr 0.9% 1.2% -0.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,125.0 Cr 1.7% 1% 1% Stock Analytics
DR REDDYS LABORATORIES ₹104,827.0 Cr -0.5% -4.2% -6.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.5%

-3.5%

-10.6%

SENSEX

1.8%

1.9%

2.4%


You may also like the below Video Courses